Wound Care in Dermatology: The Executive Brief
Dermatologists don’t need to enter wound care — many already are. Here’s why that matters, and how NuVida and Atlas|CD support the full continuum of care, conservative to advanced.
Dermatologists Don’t Need to Enter Wound Care. They’re Already In It.
Dermatologists are the experts in skin. Dermatology already manages skin across a spectrum — from a surgical defect to chronic ulceration in a medically complex patient. What’s often missing is a deliberate pathway for the wounds that don’t resolve on their own.
Wound management begins with identifying why a wound isn’t progressing — not simply selecting a product. NuVida supports the full continuum of care, conservative to advanced.
Where It Intersects With Dermatology
Four clinical contexts already inside a typical dermatology panel.
Acute & Traumatic Wounds
Lacerations, avulsions, and other traumatic injuries sometimes call for closure options beyond primary repair alone.
Post-Procedural Wounds
Biopsy and excision (Mohs) sites occasionally heal slower than expected.
Chronic Wounds
A wound that stalls warrants a structured reassessment — not just a continued dressing.
Complex & Atypical Wounds
Unclear etiology deserves dermatologic evaluation before a plan is set.
Wound Care Through an Enterprise Lens
For Medical Directors, COOs, CFOs, Compliance and Legal, and Platform Leadership, the opportunity breaks into four parts.
Clinical
A consistent and reproducible pathway for evaluating and managing appropriate wounds.
Integrative
One insurance verification, ordering, and documentation workflow at every location.
Compliance
A single, auditable record of verification, documentation, and order history behind every conservative and advanced solutions offered.
Enterprise
Infrastructure built once, deployed everywhere — one location or fifty.
As a program moves from one location to many, the risk that scales fastest isn’t clinical — it’s inconsistency. Compliance means every site runs the same verification, documentation, and ordering sequence, with a lot-level audit trail behind every allograft. Atlas|CD makes that trail structural rather than something reviewed after the fact.
Why Now?
Trade press has covered a maturing wave of dermatology PE consolidation, a persistent Mohs-surgeon shortage, and an aging patient population with more wound-relevant comorbidities. None of it requires a group to become a wound-care company — it rewards the ones building a standardized pathway before they’re forced to.
A Changing Environment
Reimbursement and regulatory policy for skin substitutes continues to evolve; specifics vary by payer and are outside the scope of this page. What doesn’t change: documentation, verified eligibility, and a consistent process behind every order.
General industry context, not financial, legal, or coding advice.
A clinical capability becomes a scalable service line only when the workflow can be integrated across providers and locations.
The NuVida Difference
Science, tissue technology, workflow, and support, working together.
Quality Assurance
Section 361 HCT/Ps processed by AATB-accredited RegenTX Partners.
Science-Backed
Full-thickness constructs retain all three native layers. Peer-reviewed characterization documents the structural difference — not a healing claim.
Powered by Atlas|CD
Verification, ordering, documentation, and lot tracking in one platform — not fax and phone tag.
Clinician Focused
Built to remove administrative friction, from 24-hour IVR turnaround to automatic notifications.
Patient Driven
The objective stays constant regardless of scale: responsible, well-documented care.
Science & Evidence
The tissue itself, examined structurally — not just described.
Placental tissue is a natural, three-layer structure. Full-thickness allografts — caregraFT™ and completeFT™ — retain all three native layers: amnion, intermediate layer, and chorion. Peer-reviewed characterization (Singh et al., International Journal of Molecular Sciences, 2025) documents the structural composition of these tri-layer constructs.
Illustrative tissue configuration — not to scale. Structural composition per Singh et al., International Journal of Molecular Sciences, 2025.
The tissue is only one part of the solution. Evidence, workflow, technology, and support determine whether a program can operate effectively. See why this science matters →
One Clinical Opportunity. One Operational Workflow.
Powered by Atlas|CD — the same pipeline your team and ours both see.
Integrates With the Systems You Already Run
Atlas|CD is built to run inside an organization’s existing operations rather than alongside them. Verification, documentation, and order records can be aligned with the procurement and ERP systems a group already uses — including platforms such as Coupa — so requisitions, approvals, and invoicing follow the process your organization has already standardized on. Integration scope varies by system and is confirmed during onboarding.
Built Beyond the Single Practice
The same infrastructure runs whether you’re coordinating one location or a hundred providers.
Building the Service Line
A general framework NuVida can guide a practice through — not a guaranteed timeline.
Evaluate & Plan
Assess your patient population, identify relevant pathways, and set protocols for when advanced management is medically necessary.
Build & Launch
Educate providers and staff, configure Atlas|CD workflows, and launch at a single pilot location.
Measure & Expand
Track performance, refine the protocol, and expand where clinically and operationally appropriate.
What Dermatology Leaders Ask Us
Where does wound care fit within dermatology?
Dermatologists are the experts in skin. Dermatology already manages skin across a spectrum — from surgical defects to chronic ulceration in medically complex patients. Wound care spans a full continuum, conservative to advanced — a set of tools for a subset of patients already within that scope, not a separate specialty to build from scratch.
How does this integrate with Mohs and surgical dermatology workflows?
It sits downstream of the surgical decision, not in place of it. Closure strategy remains a case-by-case clinical call; advanced allografts are one option a surgeon may weigh alongside standard closure techniques.
How is insurance verified, and how are products ordered?
Directly through Atlas|CD — no fax, no phone tag. IVR requests are submitted in the patient’s profile and typically reviewed within 24 hours, with a clear approved, pending, or denied status.
How does this scale across multiple offices?
The same workflow runs at every location. Group and PE-backed practices get consolidated, role-based visibility across locations in Atlas|CD, while each site’s patient data stays private to that site.
What evidence supports the products?
caregraFT™ and completeFT™ are full-thickness, tri-layer allografts. Peer-reviewed characterization (Singh et al., 2025) documents the structural composition of these tri-layer constructs — see Science & Evidence above for specifics and caveats.
How are the tissues regulated?
caregraFT™ and completeFT™ are HCT/Ps regulated under Section 361 and 21 CFR Part 1271.
What training and support does NuVida provide?
Our team supports onboarding, walks staff through the verification and ordering workflow, and remains a direct point of contact by phone or email — not a general support queue.